NDRA - ENDRA Life Sciences Inc Debt to Book Capitalization Ratio

The debt-to-equity ratio chart reflects the deployment dynamics of the TAEUS platform's AI algorithms for steatosis analysis. The current 0.07 metric determines this level of financial leverage. ENDRA Life Sciences (NDRA) is burning capital on R&D for imaging systems while revenue remains absent. Meanwhile, the unique thermoacoustic method for diagnosing liver obesity allows ENDRA Life Sciences (NDRA) to maintain pricing power by optimizing clinic costs.

Fundamental asset screening begins with an assessment of the issuer's financial stability. This indicator calculates the proportion of borrowed funds relative to equity to measure insolvency risk. By analyzing the historical trend of the debt-to-equity ratio, an investor determines the balance between expansion and security. For ENDRA Life Sciences (NDRA), this is critical when scaling TAEUS technology. Optimizing borrowings will allow the company to implement affordable liver screening without the threat of bankruptcy.